The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Weighing the role of concomitant medications during PD-1/PD-L1 checkpoint blockade: A preliminary analysis.
 
Alessio Cortellini
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Istituto Gentili; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche; Sanofi; Tesaro
 
Domenico Mallardo
No Relationships to Disclose
 
Maria Grazia Vitale
No Relationships to Disclose
 
Sergio Bracarda
Consulting or Advisory Role - Bayer Schering Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Exelixis/Ipsen; Ipsen; Janssen Oncology; Pfizer; Roche
 
Serena Macrini
No Relationships to Disclose
 
Pietro Di Marino
No Relationships to Disclose
 
Michele De Tursi
No Relationships to Disclose
 
Nicola Petragnani
No Relationships to Disclose
 
Clara Natoli
No Relationships to Disclose
 
Olga Nigro
No Relationships to Disclose
 
Alessandro Tuzi
No Relationships to Disclose
 
Leonardo Valerio Patruno
No Relationships to Disclose
 
Giampiero Porzio
No Relationships to Disclose
 
Katia Cannita
No Relationships to Disclose
 
Maria Concetta Fargnoli
Consulting or Advisory Role - Abbvie; Leo Pharma; Novartis; Sanofi
Speakers' Bureau - Abbvie; Almirall; Celgene; Galderma; Leo Pharma; Lilly; Novartis; Pierre Fabre; Roche; Sanofi
 
Corrado Ficorella
No Relationships to Disclose
 
Paolo Antonio Ascierto
Stock and Other Ownership Interests - PrimeVax
Consulting or Advisory Role - 4SC; Alkermes; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Idera; Immunocore; Incyte; Italfarmaco; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Sandoz; Sanofi; Sun Pharma; Syndax; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme